PROM1 and cancer: Recently, Prominin-1 (CD133) has been considered to be a CSC marker in many types of cancers, such as breast [23]–[25], colorectal [19], [20], brain [26], [27], prostate [28], pancreatic [29], and gastric cancers [30].